HI
BIVV

Hudock Inc’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Hudock Inc’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-50
Closed -$2K – 720
2017
Q4 		$2K Hold
50
– – ﹤0.01% 598
2017
Q3 		$2K Hold
50
– – ﹤0.01% 597
2017
Q2 		$3K Hold
50
– – ﹤0.01% 516
2017
Q1 		$2K Buy
+50
New +$2.46K ﹤0.01% 526

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Hudock Inc's BIVV Position: Q1 2018 in Review

Hudock Inc sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 50 shares — an estimated $2K sold.

Hudock Inc first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $3K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Hudock Inc reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Hudock Inc sold 50 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $2K.
  • Hudock Inc first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Hudock Inc's Bioverativ Inc. Common Stock position peaked at $3K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Hudock Inc's 13F filing for Q1 2018, filed 27 Apr 2018.